Suboxone and Belsomra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) and Belsomra (suvorexant). Common drug interactions include sleep paralysis among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Suboxone and Belsomra. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Suboxone?

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in opiate withdrawal. eHealthMe is studying from 31,249 Suboxone users. Check the latest studies of Suboxone.

What is Belsomra?

Belsomra has active ingredients of suvorexant. It is often used in insomnia. eHealthMe is studying from 12,961 Belsomra users. Check the latest studies of Belsomra.



On Jul, 17, 2026

12 people who take Suboxone and Belsomra together, and have interactions are studied.

Suboxone and Belsomra drug interactions.

What are the common drug interactions of Suboxone and Belsomra, by gender? *:

female:

  1. Sleep paralysis (waking up and unable to move or speak)
  2. Agitation (state of anxiety or nervous excitement)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Anxiety
  5. Chronic kidney disease
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Drug hypersensitivity
  8. Hallucination (an experience involving the perception of something not present)
  9. Memory impairment
  10. Ocular hypertension (intraocular pressure higher than normal)

male:

  1. Depression
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
  5. Blood creatinine increased
  6. Borderline personality disorder
  7. Concussion (short loss of normal brain function in response to a head injury)
  8. Fall
  9. Generalised anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry)
  10. Hallucination, auditory (perceiving sounds without auditory stimulus)

What are the common drug interactions of Suboxone and Belsomra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Sleep paralysis (waking up and unable to move or speak)

40-49:

  1. Dizziness
  2. Headache (pain in head)
  3. Memory impairment
  4. Nausea (feeling of having an urge to vomit)
  5. Chronic kidney disease
  6. Contusion (a type of hematoma of tissue in which capillaries)

50-59:

  1. Ocular hypertension (intraocular pressure higher than normal)
  2. Retinal pigmentation (pigmentation of retina)

60+:

  1. Agitation (state of anxiety or nervous excitement)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Anxiety
  4. Hallucination (an experience involving the perception of something not present)
  5. Sleep paralysis (waking up and unable to move or speak)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)

What are the existing conditions these people have? *

  1. Pain: 3 people, 25.00%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 25.00%
  3. Hiv Infection: 3 people, 25.00%
  4. Nausea (feeling of having an urge to vomit): 3 people, 25.00%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
  6. High Blood Cholesterol: 3 people, 25.00%
  7. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 16.67%
  8. Bacterial Infection: 2 people, 16.67%
  9. Depression: 2 people, 16.67%
  10. Eye Disorder: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Suboxone and Belsomra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Suboxone and Belsomra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Suboxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Belsomra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Suboxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Belsomra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on buprenorphine hydrochloride; naloxone hydrochloride and suvorexant (the active ingredients of Suboxone and Belsomra, respectively), and Suboxone and Belsomra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: